+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuroinflammation Drug"

Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 88 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Neuroinflammation Drug market is a subset of Central Nervous System Drugs, which are used to treat a variety of neurological conditions. Neuroinflammation drugs are used to treat conditions such as multiple sclerosis, Alzheimer's disease, and Parkinson's disease. These drugs are designed to reduce inflammation in the brain and spinal cord, which can help reduce symptoms and improve quality of life. Neuroinflammation drugs can be administered orally, intravenously, or through injections. Neuroinflammation drugs are a rapidly growing market, as the prevalence of neurological conditions increases. Research and development of new drugs is ongoing, with the aim of improving efficacy and safety. Some companies in the Neuroinflammation Drug market include Biogen, Novartis, Merck, and AbbVie. Show Less Read more